Eli Lilly



Ebit Zmiana Data
AbbVie USD 5.65B 407M 2025-03
Abbott USD 2.18B 486M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 4.8B 604M 2025-03
Baxter International USD 392M 27M 2025-03
Biogen USD 582.8M 61.3M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 3.7B 1.93B 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Indivior 71M 30M 2025-03
J&J USD 7.39B 2.04B 2025-03
Medtronic USD 2.17B 128M 2025-01
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Novo Nordisk 38.79B 4.97B 2025-03
Perrigo USD 146.6M 47.3M 2025-03
Pfizer USD 5.93B 1.31B 2025-03
Prestige Brands USD 91.96M 7.62M 2024-12
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Sanofi EUR 2.22B 2.84B 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Zoetis USD 909M 79M 2025-03



Eli Lilly - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.